A double-blind vehicle-controlled study of a preparation containing undecylenoyl phenylalanine 2% in the treatment of melasma in females

Study Design

Subject Type

Human

Trial Design

Double-Blind, Randomised, Controlled

Trial Duration

84 days

Participants

40 (37 completed)

Age Range

27-53 years

Efficacy

Intervention(s)			Outcome		Method		Effect	Description
Undecylenoyl Phenylalanine			Melasma		Clinical grading		🠫	Sign in to read for free
Sign in to read for free

Side Effects

Intervention(s)	Outcome	Effect	Description
Undecylenoyl Phenylalanine	Itching	⇧	Sign in to read for free
Sign in to read for free
Undecylenoyl Phenylalanine	Skin Discomfort	⇧	Sign in to read for free
Sign in to read for free
Undecylenoyl Phenylalanine	Skin Redness	⇧	Sign in to read for free
Sign in to read for free

Study Summary